Stayble Therapeutics AB is a Swedish public limited company governed by Swedish legislation, mainly the Swedish Companies Act (2005: 551) and the Swedish Annual Accounts Act (1995: 1554).
Following the listing of the Company’s shares on Nasdaq First North, the Company will apply and adhere to Nasdaq First North’s rules and regulations. Stayble Therapeutics AB’s auditor is RSM Göteborg KB, Göteborg. The Head Accountant is Leif Bohman. The company’s Articles of Association (in Swedish) can be found HERE.